Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: Differences between stopping and continuing the antiresorptive agent: Editorial Comment

Felicia Cosman; Robert A. Wermers; Christopher Recknor; Karen F. Mauck; Li Xie; Emmett V. Glass; John H. Krege

doi:10.1097/01.ogx.0000369681.49581.fb

Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: Differences between stopping and continuing the antiresorptive agent: Editorial Comment

Felicia Cosman, Robert A. Wermers, Christopher Recknor, Karen F. Mauck, Li Xie, Emmett V. Glass, John H. Krege

General Internal Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	179-180
Number of pages	2
Journal	Obstetrical and Gynecological Survey
Volume	65
Issue number	3
DOIs	https://doi.org/10.1097/01.ogx.0000369681.49581.fb
State	Published - Mar 1 2010

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1097/01.ogx.0000369681.49581.fb

Cite this

Cosman, F., Wermers, R. A., Recknor, C., Mauck, K. F., Xie, L., Glass, E. V., & Krege, J. H. (2010). Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: Differences between stopping and continuing the antiresorptive agent: Editorial Comment. Obstetrical and Gynecological Survey, 65(3), 179-180. https://doi.org/10.1097/01.ogx.0000369681.49581.fb

Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: Differences between stopping and continuing the antiresorptive agent: Editorial Comment. / Cosman, Felicia; Wermers, Robert A.; Recknor, Christopher et al.
In: Obstetrical and Gynecological Survey, Vol. 65, No. 3, 01.03.2010, p. 179-180.

Research output: Contribution to journal › Comment/debate › peer-review

Cosman, F, Wermers, RA, Recknor, C, Mauck, KF, Xie, L, Glass, EV & Krege, JH 2010, 'Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: Differences between stopping and continuing the antiresorptive agent: Editorial Comment', Obstetrical and Gynecological Survey, vol. 65, no. 3, pp. 179-180. https://doi.org/10.1097/01.ogx.0000369681.49581.fb

@article{ce8a1965dc92400c96fff86ba55e7f53,

title = "Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: Differences between stopping and continuing the antiresorptive agent: Editorial Comment",

author = "Felicia Cosman and Wermers, {Robert A.} and Christopher Recknor and Mauck, {Karen F.} and Li Xie and Glass, {Emmett V.} and Krege, {John H.}",

year = "2010",

month = mar,

day = "1",

doi = "10.1097/01.ogx.0000369681.49581.fb",

language = "English (US)",

volume = "65",

pages = "179--180",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene

T2 - Differences between stopping and continuing the antiresorptive agent: Editorial Comment

AU - Cosman, Felicia

AU - Wermers, Robert A.

AU - Recknor, Christopher

AU - Mauck, Karen F.

AU - Xie, Li

AU - Glass, Emmett V.

AU - Krege, John H.

PY - 2010/3/1

Y1 - 2010/3/1

UR - http://www.scopus.com/inward/record.url?scp=77949366807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949366807&partnerID=8YFLogxK

U2 - 10.1097/01.ogx.0000369681.49581.fb

DO - 10.1097/01.ogx.0000369681.49581.fb

M3 - Comment/debate

AN - SCOPUS:77949366807

SN - 0029-7828

VL - 65

SP - 179

EP - 180

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 3

ER -

Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: Differences between stopping and continuing the antiresorptive agent: Editorial Comment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this